A major step forward has been made in predicting how well melanoma patients would respond to treatment, thanks to world-leading University of Otago – ?t?kou Whakaihu Waka research.
2025
Cancer-fighting implant shows promise in treating melanoma, pancreatic and colorectal tumors
Cancer-fighting implant shows promise in treating melanoma, pancreatic and colorectal tumors
Melanoma’s Hidden Toll in Skin of Color
ATHENS, Greece — Although melanoma occurs much more frequently in people with lighter complexions, people with darker skin are also at risk, according to experts who spoke at the 11th World Congress of Melanoma and 21st EADO Congress 2025 on the challenges of diagnosing the condition in patients with dark skin.
Do Low-Grade Toxicities Affect Melanoma Treatment Success?
Among patients with stage III melanoma who received adjuvant pembrolizumab, more than 50% experienced low-grade toxicities. The results of such toxicities included patients discontinuing treatment, being hospitalized, and needing immunosuppression.